2023
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study
Price S, Palmer A, Fucito L, Graboyes E, Baker N, Rojewski A, Toll B. Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study. Cancer 2023, 129: 2385-2394. PMID: 37211959, PMCID: PMC10593116, DOI: 10.1002/cncr.34746.Peer-Reviewed Original ResearchConceptsSymptom burdenCurrent smokingCigarette smokingQuit attemptsTobacco useGreater fatiguePast-year quit attemptsCancer symptom burdenUS Population AssessmentCurrent cigarette smokingGreater symptom burdenTobacco treatment interventionsAdult cancer survivorsQuality of lifeSmoking quit attemptEmotional problemsRace/ethnicityCancer survivorsTobacco cessationHealth StudySmokingTreatment interventionsUS FoodMultivariate analysisSurvivors' interest
2019
Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment
Baldassarri SR, Fiellin DA, Savage ME, Madden LM, Beitel M, Dhingra LK, Fucito L, Camenga D, Bollampally P, Barry DT. Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment. Drug And Alcohol Dependence 2019, 197: 37-41. PMID: 30769264, PMCID: PMC6637405, DOI: 10.1016/j.drugalcdep.2018.12.012.Peer-Reviewed Original ResearchConceptsOpioid use disorderOpioid agonist therapyCurrent cigarette smokingCigarette smokingEC useHigher oddsFormer smokersLower oddsPsychiatric distressPast cigarette smokingElectronic cigarette useAgonist therapyCurrent smokersBuprenorphine treatmentChronic painTobacco useNicotine dependenceUse disordersSmokingCigarette useMultivariate analysisElectronic cigarettesSmokersCigarettesMultivariate model
2013
Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates
Leeman RF, Corbin WR, Fucito LM, Urwin JW, O’Malley S. Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates. Journal Of Addiction Research & Therapy 2013, 4: 151. PMID: 24511431, PMCID: PMC3917969, DOI: 10.4172/2155-6105.1000151.Peer-Reviewed Original ResearchClinical trialsPredictors of interestTrend-level predictorCurrent cigarette smokingNon-white raceCigarette smokingDrinking reductionsPast-year drinkersTreatment engagementHeavy drinkersReduction messagesAlcohol-related negative consequencesYoung adultsSignificant predictorsTrialsNaltrexonePredictorsRandom sampleDrinkersRegression modelsFull regression modelCounselingEquivalent levelsHigher numberMedications